Latest Articles

Publication Date
AstraZeneca Pharma India Receives CDSCO Approval for Imfinzi Cancer Treatment - scanx.trade

AstraZeneca Pharma India Receives CDSCO Approval for Imfinzi Cancer Treatment scanx.trade

Published: Feb. 10, 2026, 10:22 a.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment - IANS LIVE

AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment IANS LIVE

Published: Feb. 10, 2026, 10:07 a.m.
AstraZeneca Shares Surge 3% on CDSCO Approval for Cancer Drug - Equitypandit

AstraZeneca Shares Surge 3% on CDSCO Approval for Cancer Drug Equitypandit

Published: Feb. 10, 2026, 9:36 a.m.
AstraZeneca Imfinzi Approved in India for Endometrial Cancer - Rediff MoneyWiz

AstraZeneca Imfinzi Approved in India for Endometrial Cancer Rediff MoneyWiz

Published: Feb. 10, 2026, 8:42 a.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in endometrial cancer - Express Pharma

AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in endometrial cancer Express Pharma

Published: Feb. 10, 2026, 6:40 a.m.
Endometriosis care needs a comprehensive approach - thehindu.com

Endometriosis care needs a comprehensive approach thehindu.com

Published: Feb. 9, 2026, 7:04 p.m.
Amazon's early Presidents' Day deals include discounts on Apple, Roborock, and more - Mashable

Amazon's early Presidents' Day deals include discounts on Apple, Roborock, and more Mashable

Published: Feb. 9, 2026, 6:11 p.m.
Save $100 on the 2024 Apple Mac mini with M4 chip - Mashable

Save $100 on the 2024 Apple Mac mini with M4 chip Mashable

Published: Feb. 3, 2026, 6:49 p.m.
Five drug approvals to watch in 2026 - Drug Discovery News

Five drug approvals to watch in 2026 Drug Discovery News

Published: Feb. 3, 2026, 6:14 p.m.
Apple iPad Mini Black Friday deal: $399.99 at Amazon - Mashable

Apple iPad Mini Black Friday deal: $399.99 at Amazon Mashable

Published: Feb. 2, 2026, 6:17 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!